No Picture
Trading Ideas

Boeing, lockdown easing hopes set to lift Wall Street

The biggest U.S. planemaker soared 11.2% in premarket trading after saying it would resume commercial aircraft production next week in Washington state after halting operations last month due to the coronavirus pandemic. Late on Thursday, Trump outlined a plan to ease the shutdown in a staggered, three-stage process, but the plan was a set of recommendations rather than orders and left the decision largely up to state governors. Gilead Sciences Inc surged 11% following a media report that patients with severe symptoms of the disease had responded positively to its experimental drug, remdesivir. …read more […]

No Picture
Trading Ideas

Nervous Bankers Leave the Gold Market Stuck in Disconnect

(Bloomberg) — Gold has rarely been a hotter trade, but the world’s two most important markets remain out of sync. In New York, the price of gold topped $1,750 for the first time in seven years on April 9. In London, it still hasn’t caught up.The dislocation first blew out in late March, when disruptions from the coronavirus sparked concerns among traders about getting gold to New York in time to settle futures contracts. In a chaotic couple of days, the premium for New York futures over the London spot price rose above $70 — the highest in four decades.The …read more […]

No Picture
Trading Ideas

Coronavirus Drug Results Send Gilead Sciences Stock Flying; JPMorgan Weighs In

As the S&P 500 tumbled 15% over the past two months, shares of biotech Gilead Sciences (GILD) went in a somewhat different direction: Up 15%.And now it looks like Gilead is going up some more.New data from a University of Chicago Hospital Phase 3 clinical trial of Gilead’s remdesivir antiviral drug, also known as “GS-5734” shows promising results for the drug’s efficacy in treating the novel coronavirus. And no sooner had the data come out, than Gilead’s stock price began marching higher again, rising 12% in pre-market trading on Friday.So what did the data show, exactly?The study in question involved …read more […]

No Picture
Trading Ideas

Megvii IPO: Blacklisted Chinese Company Files with Hong Kong

In the summer of 2019, a Megvii IPO was filed with the Hong Kong Exchange. Investors thought they could expect Megvii stock soon after. However, those expectations were not met.
Megvii isn’t a public company yet. But investors shouldn’t worry. The Megvii IPO is on its way. Here’s what we know…
Megvii IPO: The Business

Yin Qi founded Megvii in 2011 with friends Tang Wenbin and Yang Mu. Qi is CEO of the Chinese technology company. It designs image recognition and deep-learning software. One of Megvii’s better known platforms is Face++ for facial recognition.
Megvii’s technology is used by governments and businesses. Some companies …read more […]

No Picture
Trading Ideas

Procter & Gamble Posts Earnings Beat, But Revenue Falls Short

Procter & Gamble (PG) has reported an earnings beat for the third quarter of fiscal year 2020 driven by strong organic sales figures. Third quarter Non-GAAP EPS of $1.17 beat the consensus estimate by $0.04.However, revenue of $17.21 billion (up 4.6% year-over-year) missed the Street’s expectations by $80 million. Shares are rising marginally higher in Friday’s pre-market trading.“Organic shipment volume increased six percent as strong consumer demand in North America and certain European markets due to the COVID-19 pandemic was partially offset by volume decreases in certain Asian markets due primarily to temporary disruption of consumer access to retail markets …read more […]

No Picture
Trading Ideas

Goldman predicts 36% drop in iPhone shipment, says time to sell Apple shares

The brokerage noted that average selling prices for consumer devices are likely to decline during a recession and remain weak well beyond the point when units recover. Earlier this week, Apple released a smaller iPhone priced at $399, lowering the starting price for the company’s smartphone line to broaden its appeal among budget-conscious customers. …read more […]